BACKGROUND: Tissue factor (TF) is present in blood in various forms, including small membrane vesicles called microparticles (MPs). Elevated levels of these MPs appear to play a role in the pathogenesis of thrombosis in a variety of diseases, including sepsis. OBJECTIVE: Measure levels of MP TF activity and activation of coagulation in control and endotoxemic mice. MATERIALS AND METHODS: MPs were prepared from plasma by centrifugation. The procoagulant activity (PCA) of MPs was measured using a two-stage chromogenic assay. We also measured levels of thrombin-antithrombin and the number of MPs. RESULTS: Lipopolysaccharide (LPS) increased MP PCA in wild-type mice; this PCA was significantly reduced by an anti-mouse TF antibody (1H1) but not with an anti-human TF antibody (HTF-1). Conversely, in mice expressing only human TF, MP PCA was inhibited by HTF-1 but not 1H1. MPs from wild-type mice had 6-fold higher levels of PCA using mouse factor (F)VIIa compared with human FVIIa, which is consistent with reported species-specific differences in FVIIa. Mice expressing low levels of human TF had significantly lower levels of MP TF activity and TAT than mice expressing high levels of human TF; however, there were similar levels of phosphatidylserine (PS)-positive MPs. Importantly, levels of MP TF activity in wild-type mice correlated with levels of TAT but not with PS-positive MPs in endotoxemic mice. CONCLUSION: These results suggest that the levels of TF-positive MPs can be used as a biomarker for evaluating the risk of disseminated intravascular coagulation in endotoxemia.
BACKGROUND:Tissue factor (TF) is present in blood in various forms, including small membrane vesicles called microparticles (MPs). Elevated levels of these MPs appear to play a role in the pathogenesis of thrombosis in a variety of diseases, including sepsis. OBJECTIVE: Measure levels of MP TF activity and activation of coagulation in control and endotoxemic mice. MATERIALS AND METHODS: MPs were prepared from plasma by centrifugation. The procoagulant activity (PCA) of MPs was measured using a two-stage chromogenic assay. We also measured levels of thrombin-antithrombin and the number of MPs. RESULTS:Lipopolysaccharide (LPS) increased MP PCA in wild-type mice; this PCA was significantly reduced by an anti-mouseTF antibody (1H1) but not with an anti-humanTF antibody (HTF-1). Conversely, in mice expressing only humanTF, MP PCA was inhibited by HTF-1 but not 1H1. MPs from wild-type mice had 6-fold higher levels of PCA using mouse factor (F)VIIa compared with human FVIIa, which is consistent with reported species-specific differences in FVIIa. Mice expressing low levels of humanTF had significantly lower levels of MP TF activity and TAT than mice expressing high levels of humanTF; however, there were similar levels of phosphatidylserine (PS)-positive MPs. Importantly, levels of MP TF activity in wild-type mice correlated with levels of TAT but not with PS-positive MPs in endotoxemic mice. CONCLUSION: These results suggest that the levels of TF-positive MPs can be used as a biomarker for evaluating the risk of disseminated intravascular coagulation in endotoxemia.
Authors: R F Franco; E de Jonge; P E Dekkers; J J Timmerman; C A Spek; S J van Deventer; P van Deursen; L van Kerkhoff; B van Gemen; H ten Cate; T van der Poll; P H Reitsma Journal: Blood Date: 2000-07-15 Impact factor: 22.113
Authors: Ingrid Hrachovinová; Beatrice Cambien; Ali Hafezi-Moghadam; János Kappelmayer; Raymond T Camphausen; Angela Widom; Lijun Xia; Haig H Kazazian; Robert G Schaub; Rodger P McEver; Denisa D Wagner Journal: Nat Med Date: 2003-07-13 Impact factor: 53.440
Authors: E Biró; K N Sturk-Maquelin; G M T Vogel; D G Meuleman; M J Smit; C E Hack; A Sturk; R Nieuwland Journal: J Thromb Haemost Date: 2003-12 Impact factor: 5.824
Authors: Vladimir Y Bogdanov; Viji Balasubramanian; James Hathcock; Oana Vele; Mark Lieb; Yale Nemerson Journal: Nat Med Date: 2003-03-24 Impact factor: 53.440
Authors: Omer Aras; Arun Shet; Ronald R Bach; Jessica L Hysjulien; Arne Slungaard; Robert P Hebbel; Gines Escolar; Bernd Jilma; Nigel S Key Journal: Blood Date: 2004-02-26 Impact factor: 22.113
Authors: J E Geddings; Y Hisada; Y Boulaftali; T M Getz; M Whelihan; R Fuentes; R Dee; B C Cooley; N S Key; A S Wolberg; W Bergmeier; N Mackman Journal: J Thromb Haemost Date: 2015-12-11 Impact factor: 5.824
Authors: Birgit A Steppich; Siegmund Lorenz Braun; Andreas Stein; Gabriele Demetz; Philip Groha; Albert Schömig; Nicolas von Beckerath; Adnan Kastrati; Ilka Ott Journal: Thromb J Date: 2009-07-02